COMPANY PROFILE · UPDATED 18 NOV 2025

Iovance Biotherapeutics

Iovance Biotherapeutics is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.

San Carlos, CA · Philadelphia, PA

iovance.com ↗

Work at Iovance Biotherapeutics? Claim this profile

Healthcare & Biotech Biotech & Drug Discovery Medical Organizations Health Care Companies Public Companies In Peninsula Bay Area Biotechnology Companies

This is the record ChatGPT, Claude and Google read about Iovance Biotherapeutics. Claiming it controls the source; answers update as assistants re-crawl.

Founded: 2007
Headcount: 434
Open roles: 30
Last raised: Post Ipo Equity

LOCATIONS

Where they work

Iovance Biotherapeutics offices

Philadelphia, PA
San Carlos, CA825 Industrial Road 4th Floor

FUNDING

Capital raised

Total raised

$1,576,400,128

Investors

Broadfin Capital Frazier Management OrbiMed Advisors Quogue Capital

Funding rounds

Post Ipo Equity
$211MFeb 19, 2024
Post Ipo Equity
$150MJul 9, 2023
Post Ipo Equity
$603.7MMay 26, 2020
Post Ipo Equity
$252.2MOct 10, 2018
Post Ipo Equity
$172.5MJan 23, 2018
Post Ipo Equity
Quogue Capital, OrbiMed Advisors, Frazier Management, Broadfin Capital
$100MJun 2, 2016
Post Ipo Equity
$64MFeb 25, 2015
Post Ipo Equity
$23MOct 30, 2013
IPO
UndisclosedJan 1, 2010